cholesterol-lowering drugs might increase the risk of cancer
February 1996
Patients are concerned about recent reports that many cholesterol-lowering drugs might increase the risk of cancer.
This was triggered by an article recently published in JAMA.
The authors suggest limiting the use of "statins" such as lovastatin...and fibrates such as gemfibrozil (Lopid).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote